Description
A high-throughput single-cell technology for the function-based discovery of monoclonal antibody antagonists of G-protein coupled receptors in cancer
Amendment chain · 1 entry
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header.
- #02014-10-01$1,232,800
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2014-10-01(start date) | $1,232,800 | — | A high-throughput single-cell technology for the function-based discovery of monoclonal antibody antagonists o… |
Related records · 2
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (exact legal name match; no business number on file)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 236-2012-2013-Q1-00013 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada | $154,120 | FY2013 |
| 236-2011-2012-Q4-00417 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada | $965,950 | FY2013 |
Cite as: Glassbox record view · Federal grants & contributions · 236-2014-2015-Q2-00576 · retrieved 2026-11-14.